Friday, January 30, 2026 | 05:19 PM ISTहिंदी में पढें
Teva Pharma
Q3 Preview: Strong domestic sales set to lift pharma revenues by up to 11%
Strong domestic demand is set to lift pharma revenues by up to 11% in Q3FY26, though pressure from generic Revlimid in the US may limit profit growth
 "Q3 Preview: Strong domestic sales set to lift pharma revenues by up to 11%")
Updated On : 19 Jan 2026 | 12:04 AM IST
Gautam Adani charged by SEC: Key FCPA corruption cases and their results
US SEC accused Gautam Adani and seven others of paying $265 million in bribes to Indian government officials to secure solar energy project contracts for Adani Green Energy
 "Gautam Adani charged by SEC: Key FCPA corruption cases and their results")
Updated On : 21 Nov 2024 | 3:55 PM IST
Teva faces fine for disparaging rival multiple sclerosis medicine: Report
The EU competition enforcer's tough line underscores its concerns that such practices could stifle innovation in the pharmaceutical industry
 "Teva faces fine for disparaging rival multiple sclerosis medicine: Report")
Updated On : 10 Sep 2024 | 10:42 PM IST
US FDA nod to Teva for key specialty product to weigh on Sun Pharma
Strong US portfolio, margin gains and India business growth to support stock
 "US FDA nod to Teva for key specialty product to weigh on Sun Pharma")
Updated On : 06 Apr 2021 | 1:33 AM IST
Teva Pharma leases 5 floors in Mumbai complex
To pay Rs 20-cr rent for 150,000 sq ft in Goregaon; may be made India headquarters
 "Teva Pharma leases 5 floors in Mumbai complex")
Updated On : 19 Sep 2016 | 1:46 AM IST